ClariVest Asset Management’s MEI Pharma MEIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,690
| Closed | -$624K | – | 763 |
|
|
2021
Q4 | $624K | Sell |
11,690
-190
| -2% | -$10.1K | 0.02% | 403 |
|
|
2021
Q3 | $656K | Sell |
11,880
-75
| -0.6% | -$4.14K | 0.02% | 393 |
|
|
2021
Q2 | $681K | Buy |
11,955
+4,725
| +65% | +$269K | 0.02% | 377 |
|
|
2021
Q1 | $496K | Buy |
7,230
+405
| +6% | +$27.8K | 0.02% | 416 |
|
|
2020
Q4 | $360K | Sell |
6,825
-100
| -1% | -$5.28K | 0.01% | 439 |
|
|
2020
Q3 | $432K | Buy |
6,925
+1,280
| +23% | +$79.9K | 0.01% | 371 |
|
|
2020
Q2 | $467K | Sell |
5,645
-2,960
| -34% | -$245K | 0.01% | 412 |
|
|
2020
Q1 | $277K | Sell |
8,605
-2,915
| -25% | -$93.8K | 0.01% | 456 |
|
|
2019
Q4 | $572K | Buy |
11,520
+4,010
| +53% | +$199K | 0.01% | 417 |
|
|
2019
Q3 | $253K | Sell |
7,510
-75
| -1% | -$2.53K | 0.01% | 478 |
|
|
2019
Q2 | $379K | Sell |
7,585
-70
| -0.9% | -$3.5K | 0.01% | 388 |
|
|
2019
Q1 | $470K | Buy |
7,655
+450
| +6% | +$27.6K | 0.01% | 463 |
|
|
2018
Q4 | $380K | Sell |
7,205
-725
| -9% | -$38.2K | 0.01% | 481 |
|
|
2018
Q3 | $684K | Sell |
7,930
-570
| -7% | -$49.2K | 0.01% | 469 |
|
|
2018
Q2 | $670K | Sell |
8,500
-1,830
| -18% | -$144K | 0.01% | 487 |
|
|
2018
Q1 | $428K | Buy |
10,330
+245
| +2% | +$10.2K | 0.01% | 516 |
|
|
2017
Q4 | $423K | Hold |
10,085
| – | – | 0.01% | 509 |
|
|
2017
Q3 | $540K | Buy |
10,085
+55
| +0.5% | +$2.95K | 0.01% | 383 |
|
|
2017
Q2 | $480K | Buy |
+10,030
| New | +$480K | 0.01% | 389 |
|